Research study Program year 2021 Source: CMS Open Payments

A phase 2, multicenter, open-label, multi-cohort s

Research payments

$361,577

3 payments

Through program year 2021, $361,577 in research payments was reported against A phase 2, multicenter, open-label, multi-cohort s, across 3 payments, paid by Celgene Corporation.

Paid by: Celgene Corporation
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2021	Research	$361,577	3

Breakdown

Who paid Research payments · program year 2021

Celgene Corporation $361,577 3 payments

Who received the money Research payments · program year 2021

Upmc Health Plan Organisation paid for research $246,511 1 payment
Virginia Cancer Specialists, PC Organisation paid for research $93,355 1 payment
Memorial Sloan-kettering Cancer Center - Cancer Organisation paid for research $21,710 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

3 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.